Cencora

Cencora is a global healthcare solutions company and one of the three largest pharmaceutical wholesalers and distributors in the United States, commanding over 90% of the US pharmaceutical wholesale market alongside McKesson and Cardinal Health. Formerly known as AmerisourceBergen (formed from the 2001 merger of Bergen Brunswig and AmeriSource), the company rebranded to Cencora in August 2023. Cencora operates as a pharmaceutical supply chain intermediary, connecting manufacturers, healthcare providers, and patients through a network of over 40 U.S. distribution centers and 1,300+ global office locations in 50+ countries. Beyond traditional drug distribution, Cencora operates an integrated specialty healthcare platform that includes World Courier (global specialty logistics for time-sensitive and temperature-controlled pharmaceuticals, including cell and gene therapies), animal health distribution via MWI Animal Health, and physician practice management services including its recent acquisitions of Retina Consultants of America and pending acquisition of OneOncology. The company provides end-to-end commercialization services, logistics solutions, and patient support programs for pharmaceutical and biotech manufacturers. In fiscal 2025, Cencora generated $321.3 billion in revenue with adjusted diluted EPS of $16.00, demonstrating strong financial performance driven by specialty pharmaceuticals (which represent over 60% of revenue) and strategic vertical integration into specialty care services.